239 related articles for article (PubMed ID: 17400057)
1. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways.
Naji A; Durrbach A; Carosella ED; Rouas-Freiss N
Hum Immunol; 2007 Apr; 68(4):233-9. PubMed ID: 17400057
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
[TBL] [Abstract][Full Text] [Related]
3. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
4. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
5. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells.
Le Rond S; Azéma C; Krawice-Radanne I; Durrbach A; Guettier C; Carosella ED; Rouas-Freiss N
J Immunol; 2006 Mar; 176(5):3266-76. PubMed ID: 16493088
[TBL] [Abstract][Full Text] [Related]
6. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
[TBL] [Abstract][Full Text] [Related]
7. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells.
LeMaoult J; Krawice-Radanne I; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 2004 May; 101(18):7064-9. PubMed ID: 15103024
[TBL] [Abstract][Full Text] [Related]
8. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.
Riteau B; Rouas-Freiss N; Menier C; Paul P; Dausset J; Carosella ED
J Immunol; 2001 Apr; 166(8):5018-26. PubMed ID: 11290782
[TBL] [Abstract][Full Text] [Related]
9. Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1.
McIntire RH; Morales PJ; Petroff MG; Colonna M; Hunt JS
J Leukoc Biol; 2004 Dec; 76(6):1220-8. PubMed ID: 15459235
[TBL] [Abstract][Full Text] [Related]
10. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse.
Zhong M; Weng X; Liang Z; Lu S; Li J; Chen X; Li Q; Sun W; Song Y; Shen G; Wu X
Transplantation; 2009 Jan; 87(1):8-15. PubMed ID: 19136885
[TBL] [Abstract][Full Text] [Related]
11. Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I.
Ottonello L; Ghio M; Contini P; Bertolotto M; Bianchi G; Montecucco F; Colonna M; Mazzei C; Dallegri F; Indiveri F
Transfusion; 2007 Aug; 47(8):1395-404. PubMed ID: 17655583
[TBL] [Abstract][Full Text] [Related]
12. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?
Aractingi S; Briand N; Le Danff C; Viguier M; Bachelez H; Michel L; Dubertret L; Carosella ED
Am J Pathol; 2001 Jul; 159(1):71-7. PubMed ID: 11438456
[TBL] [Abstract][Full Text] [Related]
13. Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity.
Strauss G; Osen W; Knape I; Jacobsen EM; Müller SM; Debatin KM
Cell Death Differ; 2007 Mar; 14(3):480-8. PubMed ID: 16902496
[TBL] [Abstract][Full Text] [Related]
14. Soluble HLA-G molecules induce apoptosis in natural killer cells.
Lindaman A; Dowden A; Zavazava N
Am J Reprod Immunol; 2006 Jul; 56(1):68-76. PubMed ID: 16792533
[TBL] [Abstract][Full Text] [Related]
15. [HLA-G: immunoregulatory molecule involved in allograft acceptance].
Creput C; Durrbach A; Charpentier B; Carosella ED; Rouas-Freiss N
Nephrologie; 2003; 24(8):451-6. PubMed ID: 14737978
[TBL] [Abstract][Full Text] [Related]
16. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation.
Baştürk B; Karakayali F; Emiroğlu R; Sözer O; Haberal A; Bal D; Haberal M
Transplant Proc; 2006 Mar; 38(2):571-4. PubMed ID: 16549178
[TBL] [Abstract][Full Text] [Related]
18. [HLA-G in organ transplantation].
Le Maoult J; Rouas-Freiss N; Le Discorde M; Moreau P; Carosella ED
Pathol Biol (Paris); 2004 Mar; 52(2):97-103. PubMed ID: 15001239
[TBL] [Abstract][Full Text] [Related]
19. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
